Maintaining Treatment
What keeps you motivated to stick with your prescribed treatment? It’s different for everyone. Some people want to stay as healthy as they can so they can keep up with school, or go to work every day. Or maybe you have a trip planned with friends that you don’t want to miss. Some people stay motivated when they understand exactly what's happening in their body. Try watching the videos about CF and treatment on the Pulmozyme web site. These videos make complicated ideas easier to understand, and they might just help you stick to your prescribed treatment.
Even if you feel good, you need to keep up with your prescribed treatment so you can keep up with your busy life. If you’re taking Pulmozyme, you need to take it as prescribed by your doctor. It's always time well spent.
Keep in mind that taking Pulmozyme means using a nebulizer. Nebulizers aren’t all the same. Some will make your prescribed treatment go a little quicker, and some might have different cleaning directions. You should ask your CF Care Team to explain which is the most appropriate for your treatment as approved by the Food and Drug Administration.
Pulmozyme may help to improve lung function and reduce the risk of respiratory tract infections.
Pulmozyme should not be used in patients who are allergic to any of its ingredients.
Pulmozyme should be used in conjunction with standard therapies for CF.
During Pulmozyme therapy, patients may experience change in or loss of voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose. These side effects are usually mild and short-lived.
The video and tips below will help you learn more about the importance of your prescribed treatment.
This is not a substitute for a professional, medical diagnosis. You should ask your CF Care Team to explain which is the most appropriate for your treatment as approved by the Food and Drug Administration.
Indication and Usage
Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its ingredients
Pulmozyme should be used along with standard therapies for cystic fibrosis
When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose
These side effects are usually mild and short-lived
The effect of Pulmozyme on exercise tolerance has not been established in adults and children
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.
